🇺🇸 FDA
Patent

US 8754034

Structure-based design of peptide inhibitors of amyloid fibrillation

granted A61KA61K38/00A61P

Quick answer

US patent 8754034 (Structure-based design of peptide inhibitors of amyloid fibrillation) held by The Regents of the University of California expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K38/00, A61P, A61P25/28